Member Societies

• All
• Nov. 18 (Thu)
• Nov. 19 (Fri)
• Nov. 20 (Sat)

• KSG
• KSGE
• KASL
• KSNM
• KPBA
• KCHUGR
• KASID
• KSGC
• KSPGHAN
• Joint Session between KDDW-TDDW-JDDW
• Others
• Free Paper
• Satellite Symposium

KASL-AASLD Joint Symposium 01 (KASL) : COVID-19 and the Management of Chronic Liver Diseases English

Date / Time	Nov. 19 (Fri), 08:30-10:00
Channel	Channel 3
Chair(s)	Joong-Won Park (National Cancer Center, Korea) Steven Flamm (Northwestern Univ., USA)
Speakers	08:30-09:00	Pathogenesis and outcomes of COVID-19 in patients with chronic liver disease Andrew Moon (Univ. of North Carolina, USA)
	09:00-09:30	COVID-19 in liver transplantation Elizabeth C. Verna (Columbia Univ., USA)
	09:30-10:00	COVID-19 vaccination for patients with chronic liver diseases Won Suk Choi (Korea Univ., Infectious Diseases, Korea)

KASL-AASLD Joint Symposium 02 (KASL) : Recent Update of Fatty Liver Disease English

Date / Time	Nov. 19 (Fri), 10:15-11:45
Channel	Channel 3
Chair(s)	Seung Woon Paik (Sungkyunkwan Univ., Korea) Mauricio Lisker-Melman (Washington Univ., USA)
Speakers	10:15-10:45	A unique phenotype of NAFLD: NAFLD with sarcopenia Won Kim (Seoul National Univ., Korea)
	10:45-11:15	Recent updates of clinical trials on NASH Mary Eugenia Rinella (The Univ. of Chicago, USA)
	11:15-11:45	Influence of NAFLD on chronic hepatitis B and C Seung Up Kim (Yonsei Univ., Korea)

KASL-AASLD Joint Symposium 03 (KASL) : Changes in the Management of Chronic Hepatitis B English

Date / Time	Nov. 19 (Fri), 12:25-13:55
Channel	Channel 3
Chair(s)	Jung-Hwan Yoon (Seoul National Univ., Korea) Joseph Ahn (Oregon Health Science Univ., USA)
Speakers	12:25-12:55	Artificial intelligence-driven HCC prediction model for patients with chronic hepatitis B Hwi Young Kim (Ewha Womans Univ., Korea)
	12:55-13:25	Expanding treatment criteria for chronic hepatitis B Young-Suk Lim (Univ. of Ulsan, Korea)
	13:25-13:55	Recent updates of clinical trials on functional cure of chronic hepatitis B W Ray Kim (Stanford Univ., USA)

Basic/Translational Symposium 04 (KASL) : Basic Science Forum of Liver Disease: Metabolic Approaches for the Translational Medicine of Liver Diseases English

Date / Time	Nov. 19 (Fri), 14:10-15:40
Channel	Channel 3
Chair(s)	Young Oh Kweon (Kyungpook National Univ., Korea) Si Hyun Bae (The Catholic Univ. of Korea, Korea)
Speakers	14:10-14:32	Small intestinal dietary fructose metabolism prevents non-alcoholic fatty liver disease Cholsoon Jang (Univ. of California, Irvine, USA)
	14:32-14:54	Microbial metabolites entering into the liver: The role in diabetes and drug responses Ara Koh (POSTECH, Korea)
	14:54-15:16	Fructose modulates leaky gut, endotoxemia and liver fibrosis through CYP2E1-mediated oxidative and Nitrative stress Young-Eun Cho (Andong National Univ., Food and Nutrition, Korea)
	15:16-15:38	Role of diabetes on the risk of hepatocellular carcinoma in cirrhosis patients with NAFLD Ju Dong Yang (Cedars-Sinai Medical Center, USA)

Multidisciplinary Session 02 (KASL) : Comprehensive Multidisciplinary Approach for Obesity and/or NAFLD Korean

Date / Time	Nov. 19 (Fri), 15:55-17:25
Channel	Channel 3
Chair(s)	Sung Kyu Choi (Chonnam National Univ., Korea) So Young Kwon (Konkuk Univ., Korea)
Speakers	15:55-16:17	Clinical significance of obese and non-obese Fatty Liver Disease Jeongju Yoo (Soonchunhyang Univ., Korea)
	16:17-16:39	Radiological assessment of NAFLD Dong Ho Lee (Seoul National Univ., Radiology, Korea)
	16:39-17:01	Endoscopic therapies for obesity in NAFLD Seung-Joo Nam (Kangwon National Univ., Korea)
	17:01-17:23	Bariatric surgery in the management of obesity in NAFLD Jong-Han Kim (Korea Univ., Surgery, Korea)